ezogabine and diclofenac
ezogabine has been researched along with diclofenac in 5 studies
Compound Research Comparison
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (diclofenac) | Trials (diclofenac) | Recent Studies (post-2010) (diclofenac) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 8,874 | 1,874 | 3,616 |
Protein Interaction Comparison
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Darvesh, AS; Geldenhuys, WJ; Leeper, TC; Morris, DL; Sullivan, PG; Yonutas, HM | 1 |
| Attali, B; Degani, N; Gibor, G; Nachman, R; Peretz, A; Shabat, D; Uziyel, Y | 1 |
| Kaba, H; Takahashi, Y | 1 |
| Díaz, AL; Etchenique, R; Murer, MG; Paz, RM; Rela, L; Stahl, A; Tubert, C | 1 |
Reviews
1 review(s) available for ezogabine and diclofenac
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
Other Studies
4 other study(ies) available for ezogabine and diclofenac
| Article | Year |
|---|---|
Identification of small molecules that bind to the mitochondrial protein mitoNEET.
Topics: Hypoglycemic Agents; Ligands; Mitochondrial Proteins; Protein Binding; Small Molecule Libraries; Thiazolidinediones | 2016 |
Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
Topics: Action Potentials; Animals; Anticonvulsants; Carbamates; Cerebral Cortex; CHO Cells; Cricetinae; Diclofenac; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Meclofenamic Acid; Phenylenediamines; Potassium Channels, Voltage-Gated; Rats; Rats, Sprague-Dawley | 2005 |
Muscarinic receptor type 1 (M1) stimulation, probably through KCNQ/Kv7 channel closure, increases spontaneous GABA release at the dendrodendritic synapse in the mouse accessory olfactory bulb.
Topics: Alkaloids; Animals; Anticonvulsants; Calcium; Calcium Channel Blockers; Calcium Channels, R-Type; Carbachol; Carbamates; Cholinergic Agonists; Dendrites; Diclofenac; Excitatory Amino Acid Antagonists; Furans; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Ion Channel Gating; KCNQ Potassium Channels; Mice; Mice, Inbred BALB C; Muscarinic Antagonists; Naphthalenes; Nimodipine; Olfactory Bulb; Patch-Clamp Techniques; Phenylenediamines; Piperidines; Pirenzepine; Potassium Channel Blockers; Receptor, Muscarinic M1; Receptors, Glutamate; Synapses | 2010 |
Inhibition of striatal cholinergic interneuron activity by the Kv7 opener retigabine and the nonsteroidal anti-inflammatory drug diclofenac.
Topics: Acetylcholine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbamates; Corpus Striatum; Diclofenac; Excitatory Postsynaptic Potentials; Interneurons; Male; Membrane Transport Modulators; Mice, Transgenic; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Tissue Culture Techniques | 2018 |